Furthermore, inhibition of TRAIL-R2 expression markedly reduces primary tumor formation in an orthotopic PDAC xenograft model, as well as the number of macroscopic liver metastases following primary tumor resection [24,36]. This evidence concerns the gene TNFRSF10B and neoplasm.